Publications by authors named "Geoffrey B Johnson"

Claim this Profile
L
Localization of PSMA-avid lesions on PSMA PET-CT on prostate MRI in patients with PI-RADS 3.
Hiroaki Takahashi, Hirotsugu Nakai, Karla V Ballman, Derek J Lomas, Lance A Mynderse, Geoffrey B Johnson

Abdom Radiol (NY)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Performance of Tc-PYP versus Tc-HMDP for Cardiac Amyloid Radionuclide Imaging.
Gregorio Tersalvi, Patricia Carey, Armin Garmany, Christopher G Scott, Daniel R Davies, Geoffrey B Johnson

J Nucl Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Performance and Interpreter Experience of 1-Hour Versus 3-Hour Tc-HMDP Cardiac Amyloid Radionuclide Imaging: A Prospective, Blinded Comparison.
Gregorio Tersalvi, Patricia Carey, Armin Garmany, Christopher G Scott, Jun Zhang, Geoffrey B Johnson

Circ Cardiovasc Imaging· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematologic dysfunction and myeloid neoplasm risk in patients treated with lutetium prostate-specific antigen membrane therapy.
Yael Kusne, Osama M Mosalem, Jaxon Quillen, Skye Buckner-Petty, Miguel Muniz, Geoffrey B Johnson

Haematologica· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for [Lu]Lu-PSMA-617 with and Without Concurrent Use of Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration-resistant Prostate Cancer.
Miguel Muniz, Oliver Sartor, Jacob J Orme, Regina M Koch, Zachary Scharf, Geoffrey B Johnson

Eur Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Lu] Lu-PSMA-617 treatment for metastatic castration-resistant prostate cancer (mCRPC) with cerebral and cerebellar metastases.
Gokce Belge Bilgin, Cem Bilgin, Brian J Burkett, Matthew P Thorpe, Ann T Packard, Geoffrey B Johnson, Derek R Johnson

Eur J Nucl Med Mol Imaging· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and future directions in theranostics for neuroendocrine prostate cancer.
Gokce Belge Bilgin, Fabrice Lucien-Matteoni, Aadel A Chaudhuri, Jacob J Orme, Daniel S Childs, Derek R Johnson, Geoffrey B Johnson

Cancer Treat Rev· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-field prostate cancer recurrence following radical prostatectomy and salvage radiation.
Austin Martin, Ahmed M Mahmoud, Cameron J Britton, Anthony Fadel, Mohamed E Ahmed, Geoffrey B Johnson

BJU Int· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [Lu]Lu-PSMA-617.
Miguel Muniz, Oliver Sartor, Jacob J Orme, Regina M Koch, Hana R Rosenow, Geoffrey B Johnson

J Nucl Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Evaluation of the Treatment Effects of Rituximab in Patients with Progressive and Symptomatic Fibrosing Mediastinitis.
Cyril Varghese, Geoffrey B Johnson, Patrick W Eiken, Eric S Edell, Ulrich Specks

Ann Am Thorac Soc· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection rate of gastrin-releasing peptide receptor (GRPr) targeted tracers for positron emission tomography (PET) imaging in primary prostate cancer: a systematic review and meta-analysis.
Gokce Belge Bilgin, Cem Bilgin, Atakan Orscelik, Brian J Burkett, Matthew P Thorpe, Derek R Johnson, Geoffrey B Johnson

Ann Nucl Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurologic Symptoms After Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience.
Gokce Belge Bilgin, Brian J Burkett, Cem Bilgin, Jacob J Orme, Daniel S Childs, Derek R Johnson, Geoffrey B Johnson

J Nucl Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Patterns Based on First-site-specific Visceral Metastatic Prostate Cancer: Are Outcomes of Visceral Metastases the Same?
Mohamed E Ahmed, Ahmed M Mahmoud, Guiseppe Reitano, Wael Zeina, Kelly Lehner, Geoffrey B Johnson

Eur Urol Open Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer Lu-PSMA-617 therapy.
Gokce Belge Bilgin, Cem Bilgin, Daniel S Childs, Jacob J Orme, Brian J Burkett, Derek R Johnson, Geoffrey B Johnson

Front Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going.
Miguel Muniz, Charles L Loprinzi, Jacob J Orme, Regina M Koch, Ahmed M Mahmoud, Geoffrey B Johnson

Cancer Treat Rev· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversibility of Bicalutamide PSMA PET-Positive Gynecomastia With Androgen Deprivation Therapy.
Miguel Muniz, Daniel S Childs, Jacob J Orme, Geoffrey B Johnson, Oliver Sartor

Clin Nucl Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Theranostics and artificial intelligence: new frontiers in personalized medicine.
Gokce Belge Bilgin, Cem Bilgin, Brian J Burkett, Jacob J Orme, Daniel S Childs, Geoffrey B Johnson

Theranostics· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low PSA radiographic disease progression on C11-choline PET.
Ahmed M Mahmoud, Mohamed E Ahmed, A Tuba Kendi, Matthew Thorpe, Geoffrey B Johnson

BJUI Compass· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasis.
Ahmed M Mahmoud, Daniel S Childs, Mohamed E Ahmed, A Tuba Kendi, Geoffrey B Johnson

Prostate· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of the RAPID-WATER-FLOW trial: Radiolabeled perfusion to identify coronary artery disease using water to evaluate responses of myocardial FLOW.
Marcelo F Di Carli, Lars C Gormsen, Panithaya Chareonthaitawee, Geoffrey B Johnson, Rob Beanlands

J Nucl Cardiol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Advanced Imaging to Prostate Cancer Diagnosis and Management: A Narrative Review of Current Practice and Unanswered Questions.
Elizabeth L McKone, Elsa A Sutton, Geoffrey B Johnson, Ryan M Phillips

J Clin Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACR Appropriateness Criteria® Incidentally Detected Indeterminate Pulmonary Nodule.

J Am Coll Radiol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology.
Patrick Veit-Haibach, Håkan Ahlström, Ronald Boellaard, Roberto C Delgado Bolton, Swen Hesse, Geoffrey B Johnson

Eur J Nucl Med Mol Imaging· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of Theranostics: Perspectives on Emerging Approaches and Clinical Advancements.
Brian J Burkett, David J Bartlett, Patrick W McGarrah, Akeem R Lewis, Derek R Johnson, Geoffrey B Johnson

Radiol Imaging Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Alpha-Particle Therapy: A Review of Current Trials.
Albert Jang, Ayse T Kendi, Geoffrey B Johnson, Thorvardur R Halfdanarson, Oliver Sartor

Int J Mol Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis